Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R-YAP Axis.
Zhu H, Wang DD, Yuan T, Yan FJ, Zeng CM, Dai XY, Chen ZB, Chen Y, Zhou T, Fan GH, Ying M, Cao J, Luo P, Liu XJ, Hu Y, Peng Y, He Q, Yang B.
Zhu H, et al.
Cancer Res. 2018 Jul 15;78(14):3995-4006. doi: 10.1158/0008-5472.CAN-17-1548. Epub 2018 Apr 18.
Cancer Res. 2018.
PMID: 29669759